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Abstract 
Objective 
Severity stratification in acute pancreatitis is needed both to guide clinical practice and 
recruit patients into studies. 
Methods 
Patients with a clinical acute pancreatitis (N=181) were recruited prospectively, and organ 
dysfunction scores ( LODS, MODS and SOFA), C-reactive protein (CRP) and APACHE II 
scores were collected.  Patients who died or used critical care (level II/III) during admission 
were classed as ‘severe’ cases.  The ability of tests to accurately select patients was 
assessed.     
Results  
The ability of test measures to accurately select severe cases within the first 24 hours of 
admission was inadequate. At 24 hours, for a LODS score ≥ 1, sensitivity of 90% and 
specificity of 68% equated to a positive predictive value of 35%: only one in three patients 
selected for enhanced care would subsequently prove to be a severe case, although only 
10% of severe cases would be missed. The use of multiple tests is unlikely to be helpful 
given the degree of correlation between measures. 
Conclusion 
Current tissue damage and organ dysfunction scoring methods are inadequate to select 
patients to guide subsequent care or for involvement in studies. New, better methods are 
necessary. 
 
[Abstract word count: 189]. 
 
 Key words: Acute pancreatitis, organ dysfunction, severity stratification.  
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Introduction 
The 1992 Atlanta consensus conference defined two broad categories of acute pancreatitis 
– mild and severe1.  Although there is a broad spectrum of disease severity in this illness2, 
the distinction was relevant in terms of clinical management and remains pertinent today as 
newer interventions should be targeted at individuals with severe acute pancreatitis. 
However, two limitations to do with definition and timing are apparent in the original Atlanta 
classification.   
Severe acute pancreatitis was defined as pancreatitis with organ failure and/or local 
complications1.  Organ dysfunction is ‘transient’ in some patients3 – and these patients with 
transient organ dysfunction often have a mild clinical course with early recovery and 
discharge from hospital whereas strict application of Atlanta criteria would demand that they 
be noted as severe.  Although the majority of patients with obvious mild or severe disease 
will be clearly defined, allocation is less clear for individuals with transient severe disease, 
giving rise to scope for inter-observer variation: such variation reduces comparability 
between units in activity levels and health outcomes, when analysed by severity. 
A major limitation of the Atlanta classification is that it provides post-episode classification 
and was never intended to provide prognostic information at the point of (or soon after) 
admission.  There is a major need to differentiate high and low risk patients at, or soon after, 
admission both to optimise subsequent clinical care and to select consistently high risk 
patients for new studies.  Failure to accurately predict severe disease may lead to 
confounding within and between studies due to a varying proportion of patients with mild 
illness4.   
The goal of early patient classification is to identify all patients accurately into severe and 
mild categories.  Thus the utility of any method of classification is found in its test sensitivity 
and sensitivity (see Table 1) – the proportion of disease accurately classified.  In addition, to 
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efficiently select patients for early critical management, a test must deliver a high positive 
predictive value or valuable critical care services are occupied unnecessarily.  
Patient identification for selection into studies has a different emphasis, since the objective is 
to identify a group of patients who are consistently at high risk or low risk.  It may be possible 
for a test to find such group although it may not make efficient use of all potential 
participants.  Thus the utility of selection for studies is determined particularly by the test 
positive or negative predictive values, since these determine the homogeneity of the group 
selected. 
Early identification of severe acute pancreatitis patients remains difficult despite a large body 
of research exploring biological prognostic markers5-7, multiple factor scoring systems8,9 or 
permutations of these7.  As severe acute pancreatitis is accompanied by a systemic 
inflammatory response and multiple organ dysfunction10, useful prognostic information may 
be gained from organ failure scoring systems currently used in critical care.  Systems such 
as the logistic organ dysfunction score (LODS)11 and the Marshall organ dysfunction score 
(MODS)12 are well validated for prognostic use in critical care populations, although their 
performance specifically in acute pancreatitis is less well understood. 
Seeking to improve the early management of acute pancreatitis, this paper explores the 
performance of scoring systems derived and validated in critical care medicine to categorize 
severity in acute pancreatitis.  Organ dysfunction scoring in this context has several 
theoretical attractions: the score is completed by assessing a relevant and comprehensive 
biologic dataset; and, these data inform the need for critical care admission in addition to 
identifying patients at risk of adverse outcome. 
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 Methods 
Patients and setting 
The study was undertaken in a Manchester Royal Infirmary, England - a university teaching 
hospital serving an urban population of mixed ethnicity. A consecutive series of 181 patients, 
with a clinical diagnosis of acute pancreatitis (AP) presenting from February 2001 to 
November 2004, was enrolled prospectively into the study.  The clinical diagnosis of AP was 
based on a combination of acute abdominal pain, three-fold elevation of serum amylase and 
appropriate clinical features.  Patients with known chronic pancreatitis and those tertiary 
transfers of patients with on-going pancreatic necrosis were excluded from the study. 
Data collection 
Patient-level data included demographics, ætiology of acute pancreatitis, duration of 
inpatient stay (by level of dependency), surgical/radiological interventions and mortality.  
APACHE II, Logistic Organ Dysfunction Score (LODS), Marshall Organ dysfunction score 
(MODS) and Sequential Organ Failure Score (SOFA) were estimated at admission, at 24 
and 48 hours and 7 days.  Day 7 data were only collected in those individuals who were still 
in-patients.  Additionally C-reactive protein (CRP) was measured at 48 hours. The hepatic 
score component of LODS was omitted to avoid potential bias in patients with gallstone-
related disease.  Ætiologies were categorised for the purposes of analysis into: gallstone, 
alcohol-related, idiopathic, post-endoscopic retrograde cholangiopancreatography (ERCP) 
and other. 
Data analysis 
In-hospital death or use of critical care stay (level II and level III support)14 was selected as 
the principal endpoint against which organ dysfunction scoring systems were tested.  This 
endpoint is the most objective marker of severe disease available. Duration of hospital stay 
was also explored initially but was considered prone to variation between healthcare 
systems for reasons not directly related to disease severity15. 
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Receiver operator curves were generated for each measure with area under curve (AUC) 
estimates being interpreted as a comparative measure of the potential usefulness of each 
test, and test accuracy being compared at visually optimal thresholds. Extrinsic measures 
(sensitivity and specificity) were used to assess the efficiency of the classification of cases; 
intrinsic measures (predictive values) were used to assess the adequacy of selection of 
cases by severity (see Table 1).   
Ethical approval 
Data collection for this study was under the auspices of an on-going evaluation of patients 
with acute pancreatitis and with institutional review board approval. 
Statistical analyses 
This analysis is exploratory (hypothesis generating) and concerned with estimating the 
accuracy of potential candidate tests to identify high and low risk patients.  Consequently 
AUC estimates are reported with 95% confidence intervals, and no adjustment is made for 
multiple comparisons. Data were analysed using SPSS release 15. 
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Results 
Ætiology and episode severity 
The underlying ætiology of acute pancreatitis in this cohort was: gallstones 96 (53%), 
alcohol-related 42 (23%), idiopathic 27 (15%), post-ERCP 10 (6%) and 6 (3%) others.  The 
mean age was 52 (SD20, range 17 to 87), and 48% were male. In total, 29 of 181 patients 
(16%) were classified by as having a severe episode as defined by death or need for higher 
level care, and the likelihood of a severe episode was not ætiologically-related (Chi-squared 
test without trend, p = 0.987). There were 4 deaths in the study population: all were 
categorised as severe within organ dysfunction scoring systems. 
Performance of APACHE II on admission  
The distribution of admission APACHE II scores and numbers of patients subsequently 
utilising critical care is shown in Figure 1. The ability of APACHE II to predict the need for 
critical care support at various threshold scores is shown in Figure 2.  The AUC for APACHE 
II at admission was 0.75 (95%CI: 0.66 to 0.84). At a threshold of 7, sensitivity is 72% and 
specificity is 66%, which is not adequately accurate to predict need for critical care.  At this 
threshold, 28% of severe cases are missed (1-sensitivity) while a positive predictive value of 
29% means that only one in three to four patients selected for critical care (of for study 
inclusion) would subsequently be classed as severe. 
Performance of LODS, MODS, SOFA and APACHE II scores at 24 hours 
Four markers commonly used in critical-care management were evaluated at 24 hours from 
admission and are shown in Figure 3.  There is no one dominant test for all levels of test 
performance.  If high specificity is required (>90%)  then MODS, APACHE II and SOFA 
scores all perform similarly, whereas balanced sensitivity and specificity appears best 
achieved by the LODS measures.  However, the overall AUC measures are similar for all 
four, with no statistically significant differences. 
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Performance of LODS, MODS , APACHE II, SOFA and CRP at 48 hours 
At 48 hours the three organ dysfunction scores (LODS, MODS and SOFA) appear to 
perform better than APACHE II (a marker acute physiological derangement) and CRP (a 
marker of inflammation and necrosis): findings consistent with developing organ damage 
(Figure 4). Notwithstanding this qualitative finding, the overall area under curve measures 
are similar for all five, with no statistically significant differences.  The SOFA score at cut-off 
of 1 achieved 79% sensitivity and 83% specificity, but this still only equates to a positive 
predictive value of 47%. 
Identifying high and low risk patients 
Test performance by test threshold value at 24 hours from admission is shown in Table 2.  
When looking to identify ‘severe’ cases (for recruitment to studies or target care) then 
sensitivity becomes a measure of selection efficiency and positive predictive value becomes 
a measure of selection accuracy.  From Table 2, if a LODS score of one or more is used as 
the selection criterion then 90% of all (subsequently) severe cases will be included in those 
selected (sensitivity=efficiency) but only 35% of all recruits will (subsequently) be classed as 
severe (PPV=selection accuracy).  The highest selection accuracy possible with LODS is 
only 50% and then only 7% of severe cases are being included.  Looked at in this way none 
of the 24 hour test measures can achieve a recruitment purity of greater than about one half 
and so none are useful in isolation as a selection criterion to achieve a homogeneous risk 
group of patients. 
The approach can also be used to identify ‘mild’ cases.  In this instance specificity becomes 
the efficiency measure and negative predictive value (NPV) becomes the selection accuracy 
measure. For example if an APACHE score of 10 is taken as the threshold (scores of 9 or 
lower being selected) then selection accuracy will be 90% and efficiency will be 92%.  
Similarly, at admission, APACHE II is an inadequate measure to predict severe cases.  
However, it performs quite well at detecting mild cases. A test threshold of 9 (scores of 8 of 
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less being selected) gives selection accuracy of 90% and efficiency of 70%. (This finding can 
be verified visually in Figure 1). 
Combination scores 
When individual tests fail to discriminate between different cases it may be possible to use a 
sequence of tests which together provide an adequate level of diagnostic certainty.  The 
useful of this approach depends upon the tests providing sufficiently independent information 
or there is little or no increase in diagnostic yield.  At 24 hours, APACHE II, LODS, MODS 
and SOFA scores are all moderately or highly correlated (Pearson’s r ranging from 0.48 to 
0.78, p<0.01 in all comparisons).  A similar pattern was apparent for tests at 48 hours 
(APACHE II, CRP, LODS, MODS and SOFA scores: Pearson’s r ranging from 0.48 to 0.67, 
p<0.01 in all comparisons). Consequently with the tests available, combinations are unlikely 
to be helpful in identifying severe and mild cases.  In such instances, sensitivity and 
specificity can be traded against one another but it is not possible to improve both 
simultaneously. 
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Discussion  
Although acute pancreatitis comprises a continuous spectrum of disease, the original 
concept within the 1992 Atlanta classification remains useful: the stratification of patients into 
mild and severe.  Inadequate consideration of the definition of transient organ damage of 
other complications such as short-lived hypoxia or hypotension has led to coding 
inconsistencies between centres and over time, limiting the value of comparative studies 
which have used the Atlanta classification16.   
Accurately predicting severe and mild cases at (or soon after) disease onset might constitute 
a considerable advance in patient management and an important step towards reducing 
morbidity and mortality.  In this context it is suggested that transient complications should not 
be coded as severe since these are (by definition) self-correcting with due diligence on the 
part of clinician teams.  
Since 1992, major developments in critical care medicine have led to a number of validated 
organ dysfunction scores being developed, which have the advantage of being objective and 
reproducible.  Findings presented show the inability of available tests to fulfil key roles in 
managing and researching severe acute pancreatitis.  It would be beneficial to accurately 
and efficiently select severe patients to target the use critical care facilities, but this aim was 
not informed adequately by available tests. Additionally, it would be useful to accurately 
identify risk groups for inclusion in studies.  In this instance efficiency of selection is more 
negotiable since the object is to recruit a homogeneous patient group with respect to 
severity.  None of the test could adequately identify high risk groups although APACHE II 
scores could effectively select a low severity population.  Consequently the selection of high 
risk patients for new clinical trials is fraught with difficulty, since selection guided by current 
tests will deliver a very mixed severity group. 
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Table 1:  Test performance 
 
  Disease  
  Severe Mild  
Test 
+ve a b  
-ve c d  
     
Intrinsic measures: 
(read horizontally: the likelihood of positive or 
negative test finding being correct) 
Positive Predictive Value (PPV) =
ba
a
 
Negative Predictive Value (NPV) =
dc
d
 
Extrinsic measures: 
(read vertically: the likelihood that disease status 
is correctly identified) 
Sensitivity =
ca
a
,   Specificity =
db
d
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Table 2:  Acute pancreatitis test performance at 24 hours  
from admission by test threshold 
 
  
Measure 
Positive test 
threshold 
Sensitivity Specificity 
Positive 
Predictive 
Value (PPV) 
Negative  
Predictive 
Value (NPV) 
LODS 1 90% 68% 35% 97% 
 
2 48% 85% 38% 90% 
 
3 28% 92% 40% 87% 
 
4 21% 95% 46% 86% 
 
5 14% 98% 57% 86% 
 
6 7% 99% 50% 85% 
MODS 1 79% 72% 35% 95% 
 
2 45% 92% 52% 90% 
 
3 21% 97% 55% 86% 
 
4 10% 98% 50% 85% 
SOFA 1 82% 51% 24% 94% 
 
2 64% 84% 44% 93% 
 
3 43% 95% 60% 90% 
 
4 14% 97% 50% 86% 
APACHE II 2 100% 27% 21% 100% 
 
3 93% 45% 24% 97% 
 
4 90% 57% 28% 97% 
 
5 83% 62% 29% 95% 
 
6 66% 67% 28% 91% 
 
7 62% 76% 33% 91% 
 
8 62% 80% 38% 92% 
 
9 48% 87% 41% 90% 
 
10 45% 92% 52% 90% 
 
11 28% 95% 50% 87% 
 
12 17% 96% 45% 86% 
 
13 14% 97% 44% 85% 
 
14 14% 97% 50% 86% 
 
15 14% 98% 57% 86% 
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Figure 1:  Distribution of APACHE II on admission and  
subsequent death of use of critical care (level II/III) 
 
  
APACHE II
20191817161514131211109876543210
F
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20
15
10
5
0
Score Mild Severe* Total
0 15 0 15 
1 7 0 7 
2 15 1 16 
3 18 0 18 
4 17 3 20 
5 18 2 20 
6 11 2 13 
7 5 4 9 
8 12 0 12 
9 11 7 18 
10 10 0 10 
11 6 3 9 
12 1 1 2 
13 1 0 1 
14 1 1 2 
15 1 1 2 
16 0 1 1 
17 1 1 2 
18 1 0 1 
19 1 1 2 
20 0 1 1 
All 152 29 181 
* Severe: In-hospital death or critical (level II/III) 
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Figure 2:  Predictive value of APACHE II on admission by cut-off threshold.  
(key values tabulated) 
 
 
 
 
0%
20%
40%
60%
80%
100%
0% 20% 40% 60% 80% 100%
Sensitivity
1-Specificity
Score Sensitivity Specificity
APACHE (N=181) 5 86% 47%
AUC=0.75 6 79% 59%
95%CI: 0.66-0.84 7 72% 66%
8 59% 70%
9 59% 78%
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Figure 3:  Critical care markers measured at 24 hours from admission 
(key values tabulated) 
 
 
 
 
 
 
  
0%
20%
40%
60%
80%
100%
0% 20% 40% 60% 80% 100%
Sensitivity
1-Specificity
Score Sensitivity Specificity
LODS (N=181) 1 90% 68%
AUC=0.80 2 48% 85%
95%CI: 0.72-0.88
MODS N=181) 1 79% 73%
AUC=0.79 2 45% 92%
95%CI: 0.70-0.89
SOFA(N=174) 1 82% 51%
AUC=0.77 2 64% 84%
95%CI: 0.67-0.88
APACHE (N=181) 4 90% 57%
AUC=0.79 5 83% 62%
95%CI: 0.71-0.87 8 62% 80%
10 45% 92%
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Figure 4:  Critical care markers measured at 48 hours from admission 
(key values tabulated) 
 
 
 
 
 
0%
20%
40%
60%
80%
100%
0% 20% 40% 60% 80%
Sensitivity
1-Specificity
Score Sens. Spec.
LODS (N=181) 1 69% 88%
AUC=0.80 2 41% 95%
95%CI: 0.69-0.90
MODS (N=181) 1 69% 84%
AUC=0.79 2 52% 96%
95%CI: 0.69-0.90
SOFA (N=174) 1 79% 83%
AUC=0.84 2 61% 92%
95%CI: 0.74-0.93
CRP (N=180) 42 93% 46%
AUC=0.79 85 79% 64%
95%CI: 0.71-0.87 160 66% 80%
APACHE (N=180) 4 80% 64%
AUC=0.78 6 59% 76%
95%CI: 0.68-0.87 7 41% 92%
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